Loading interface...

Rinostat L Tablet

Manufactured byRPG LIFE SCIENCES LTD
ContainsLevocetirizine (2.5 mg) + Phenylephrine (10 mg)
Description
Rinostat L Tablet is a combination of Levocetirizine and Phenylephrine. It is primarily used to treat allergy symptoms (sneezing, congestion, etc.) and cold symptoms [blocked nose and sinus (hollow cavities in your skull) congestion]. It works by blocking the effect of certain chemicals in your body that are responsible for causing allergic symptoms. Some common side effects of Rinostat L Tablet are headache, dryness in the mouth, nausea and vomiting. It can also induce dizziness and drowsiness, so don't drive or do anything else that demands mental attention until you know how this medication affects you. You can take Rinostat L Tablet with or without food. The dose and duration will be determined by your doctor based on your condition. You should continue to take this medication for as long as your doctor prescribes. Abrupt discontinuation may make your symptoms reappear, and your condition may worsen. Do not give Rinostat L Tablet to children below 12 years of age due to the lack of safety and efficacy of its use. Before taking this medicine, inform your doctor if you have kidney, liver, heart disease or other medical conditions. If you are pregnant, planning to become pregnant, or are breastfeeding, consult your doctor before taking this medicine.

Side effects

Major & minor side effects for Rinostat L Tablet

  • Dry mouth
  • Sleepiness
  • Headache
  • Blurred vision
  • Diarrhoea
  • Nausea or Vomiting
  • Difficult or painful urination

Uses of Rinostat L Tablet

What is it prescribed for?

  • Allergic Rhinitis
  • Common Cold
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of Rinostat L Tablet can be observed within half an hour of taking the dose.
  • How long do the effects of this medicine last?
    The effect of Rinostat L Tablet lasts for an average duration of 24 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Avoid or limit the consumption of alcohol while you are on treatment with Rinostat L Tablet, because it may cause dizziness and drowsiness.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported for Rinostat L Tablet.
  • Can this medicine be taken during pregnancy?
    It is recommended not to take Rinostat L Tablet during pregnancy as it may be unsafe for your foetus. Hence, your physician may advise a safer alternative with the same medicinal effect based on your clinical condition.
  • Can this medicine be taken while breast-feeding?
    There is no evidence whether Rinostat L Tablet passes into breast milk. Hence, do not use it if you are breastfeeding. Your physician may advise a safer alternative with the same therapeutic effect based on your clinical condition.

Allergy

It is recommended to avoid Rinostat L Tablet if you are allergic to it. Seek immediate medical attention if you notice any symptoms of allergic reactions such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulties, etc.

Kidney Disease

Do not take Rinostat L Tablet if you have severe kidney disease with creatinine clearance of less than 10 ml/min and undergoing hemodialysis (the process of purifying blood when your kidneys do not work normally). This medicine may lead to side effects and worsen your health condition.

Galactose intolerance

Galactose intolerance is a rare condition in which your body is unable to take in/absorb the sugars, resulting in severe diarrhoea. Do not take Rinostat L Tablet because it may worsen your condition.
Warnings for special population

Pregnancy

It is recommended not to take Rinostat L Tablet during pregnancy as it may be unsafe for your foetus. Hence, your physician may advise a safer alternative with the same medicinal effect based on your clinical condition.

Breast-feeding

There is no evidence whether Rinostat L Tablet passes into breast milk. Hence, do not use it if you are breastfeeding. Your physician may advise a safer alternative with the same therapeutic effect based on your clinical condition.
General warnings

Other medicines

The use of Rinostat L Tablet may increase the risk of sleepiness and impaired thinking if you take it with other medicines like sedatives (sleep-inducing medicine). Hence, inform your doctor about all the current medicines, including any herbs or supplements before beginning treatment with this medicine.

Use in Elderly

Use Rinostat L Tablet with caution in elderly patients due to the increased risk of adverse effects. Appropriate dose adjustments may be necessary based on your clinical condition.

Use in Children

Do not give Rinostat L Tablet in children below 12 years of age because the safety and efficacy of its use are unknown.

Driving or Operating machinery

Rinostat L Tablet may cause dizziness or blurred vision. Do not drive a vehicle or operate machinery after taking this medicine.

Urinary retention

Urinary retention is a disorder in which you are unable to empty your bladder (the organ in which urine is stored) completely. If you experience difficulty in urination, discontinue the use of this medicine.

Missed Dose

If you missed a dose of Rinostat L Tablet at a given time, then take it as soon as you remember. If it is almost the time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.

Overdose

If you suspect that you might have taken an overdose of Rinostat L Tablet, go to the emergency department of your local hospital.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Avoid or limit the consumption of alcohol while you are on treatment with Rinostat L Tablet, because it may cause dizziness and drowsiness.
Interaction with Medicine

Antidiabetic drugs

Monoamine oxidase inhibitors

Antidepressants

Alprazolam

Clobazam

Disease interactions

Cardiovascular disease

Take Rinostat L Tablet with caution if you have a known history of cardiovascular diseases. This medicine may cause an increase in heart rate, high blood pressure, etc. and may worsen your condition.

Diabetes

Diabetes is an increase in blood sugar levels. Take Rinostat L Tablet with caution if you are diabetic. This medicine may cause increase in blood glucose levels. Monitor your blood sugar levels regularly while on treatment with this medicine.
Food interactions
Information not available.
Lab interactions
Information not available.
Take Rinostat L Tablet as directed by your physician. Do not take more than what is prescribed or share this medication with other people. Ensure that the course of treatment is completed. Consult your doctor if you experience any undesirable side effects. Stop taking Rinostat L Tablet at least three days before an allergy test, because it may interfere with the findings. This medicine may cause mouth dryness, keep sipping water or chew sugar-free gum.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
Rinostat L Tablet contains Levocetirizine and Phenylephrine as its major ingredients. Levocetirizine works by blocking the action of a natural substance produced in your body called histamine responsible for causing allergic symptoms. Phenylephrine acts by reducing the swelling of the blood vessels in your nasal passages, thus provides temporary relief from congestion or stuffed nose.
Legal Status

Unknown

Unknown

Unknown

Unknown

Classification

Category

Antihistamines, Decongestants

Schedule

Schedule H

Pubchem.ncbi.nlm.nih.gov. 2021. Levocetirizine. [online] Available at: < [Accessed 7 May 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/Levocetirizine>

Pubchem.ncbi.nlm.nih.gov. 2021. Phenylephrine. [online] Available at: < [Accessed 20 April 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/Phenylephrine>

CiplaMed. 2021. LEVORID D Tablets. [online] Available at: < [Accessed 18 June 2021].

https://www.ciplamed.com/content/levorid-d-tablets>

Medicines.org.uk. 2021. Levocetirizine 5 mg film-coated tablets - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 24 August 2021].

https://www.medicines.org.uk/emc/product/9917/smpc>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 27 Aug 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.